News, Visuals and Downloads Straight From Lysando
©2023 Lysando
-
All rights reserved
WeltTV about Medolysin® donation to Ukraine – Positive news of the day
Behind the scenes of Lysando – introducing Artilysin®
Resistant bacteria are on the rise! Artilysin® is our solution to the global health crisis.
A world without Superbugs: Artilysin® controls bacteria – in a good way!
Lysando AG for TV
plan b (ZDF): Kampf gegen Killerkeime!
X:ENIUS – Viren als Helfer – Phagen als Therapie
Innovation Meets Compassion: Lysando and Bamberg UA Collaborate to Tackle Antibiotic Resistance in Ukrainian Hospitals with Medolysin® Donation
Read Article
here
here
Lysando Welcomes Pharma Leader Dr. Holger Zimmermann to its Advisory Board
Read Article
here
here
Lysando Welcomes Healthcare Visionary Jorge Cortell to its Advisory Board
Read Article
here
here
Artilysin® – A Groundbreaking „Green Pharma“ Solution
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Amicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Artilysin®: Promising approach against Acinetobacter baumannii infected wounds
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Artilysin®: Fearless Into the Post-antibiotic Era
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Lysando AG and Amicogen Inc. Sign General Development Agreement
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Dr. Fabian Geldmacher is Director Strategy & Business Development
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Wilhelm von Haller is Chief Financial Officer of Lysando AG
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
AiCuris announces expansion of its collaboration with Lysando with a focus on diabetic foot infections
Read Article on
Presseportal
Presseportal
AMICOGEN Inc. and Lysando AG bring partnership to the next level with ownership participations in each other’s companies
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Lysando AG and AMICOGEN Inc. forge a strategic partnership
Read Article on
Presseportal
Presseportal
Read Article on
Businesswire
Businesswire
Alternative to antibiotics
Read Article on
Presseportal
Presseportal
The search for new antibiotics
Read Article on
Presseportal
Presseportal
What’s next after antibiotics?
Read Article on
Presseportal
Presseportal
The medical sensation
Read Article on
Presseportal
Presseportal
Medolysin® Donation to Ukraine
The current crisis in Ukraine has brought to light a perilous threat: resistant bacteria that challenge even the most potent antibiotics. Conventional treatments have proven ineffective, causing deep concern among healthcare professionals and researchers.
